Somewhat Positive News Coverage Somewhat Unlikely to Impact Neptune Technologies & Bioressources (NEPT) Stock Price

News headlines about Neptune Technologies & Bioressources (NASDAQ:NEPT) (TSE:NTB) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Neptune Technologies & Bioressources earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave headlines about the biotechnology company an impact score of 47.4026623747407 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of Neptune Technologies & Bioressources (NEPT) opened at $2.07 on Wednesday. Neptune Technologies & Bioressources has a 52 week low of $0.70 and a 52 week high of $2.20. The company has a market capitalization of $164.39, a price-to-earnings ratio of 26.13 and a beta of 1.16.

TRADEMARK VIOLATION WARNING: This story was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at

Neptune Technologies & Bioressources Company Profile

Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.

Insider Buying and Selling by Quarter for Neptune Technologies & Bioressources (NASDAQ:NEPT)

Receive News & Ratings for Neptune Technologies & Bioressources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioressources and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply